Detail akcie Takeda Pharmactl Depository Receipt online

Business Summary: Takeda Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the research, development, manufacturing and global sales of a wide range of pharmaceuticals. Its main business areas are divided into six, including gastroenterology, rare diseases, plasma-derived therapies, oncology (cancer), vaccines, and neuroscience (neuropsychiatric disorders). In research and development, the Company focuses on three priority disease areas, including gastroenterology and inflammatory diseases, neuroscience, and oncology, and also focuses on plasma-derived therapies.
Financial Summary: BRIEF: For the fiscal year ended 31 March 2026, Takeda Pharmaceutical Co Ltd (ADR) revenues decreased 2% to Y4.506T. Net income increased 78% to Y191.76B. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Research and development expenses decrease of 7% to Y675.92B (expense), Total Selling, General and Administrativ decrease of 2% to Y1.084T (expense).